Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
about
Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis.Initiation of gametocytogenesis at very low parasite density in Plasmodium falciparum infection.Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania.Effect of coadministered fat on the tolerability, safety, and pharmacokinetic properties of dihydroartemisinin-piperaquine in Papua New Guinean children with uncomplicated malaria.Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women.Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trialPiperaquine Monotherapy of Drug-Susceptible Plasmodium falciparum Infection Results in Rapid Clearance of Parasitemia but Is Followed by the Appearance of Gametocytemia.Piperaquine Population Pharmacokinetics and Cardiac Safety in Cambodia.The application of physiologically-based pharmacokinetic modelling to assess the impact of antiretroviral-mediated drug-drug interactions on piperaquine antimalarial therapy during pregnancy.Effect of food on the pharmacokinetics of piperaquine and dihydroartemisinin.Establishment of the Ivermectin Research for Malaria Elimination Network: updating the research agenda.A mechanism-based pharmacokinetic model of fenofibrate for explaining increased drug absorption after food consumption.Population Pharmacokinetics of the Antimalarial Amodiaquine: A Pooled Analysis to Optimize Dosing
P2860
Q31153944-513CDC7C-D084-4C64-A966-E68BFB924A7DQ33662226-F1A4ADF9-BDCD-430C-AC0A-E5EDBF680248Q34227179-477791EA-96FD-491A-9EC4-F374C5CAC035Q34299178-4B8CB808-4535-4008-828D-E2BF0E95FC5AQ34597891-8F3A07E7-7BC6-4450-979B-3EDF76098840Q35746240-1FC95EBD-9774-4DE2-AE90-2F9A8758FE84Q36427654-A8F47130-E4EA-4E1F-AD53-1EAE26C42003Q37003081-D92266F1-F6A7-40B4-A0CD-A38D5D11A228Q38380902-AC89EFAD-003E-40DC-B280-34BF609E175CQ40133890-7B83AFEA-40CC-4693-AFDD-895271C6F896Q41040998-DA072C8E-3EB2-499F-B07E-5318B0C0E234Q42414575-416AF49B-06B6-42F6-9B07-3266E397AA08Q49165101-53650B66-FEC2-4850-B039-F823BB3B162BQ56358106-8FEF248B-4F4C-401D-B06E-87E0BD08B2F7
P2860
Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Population pharmacokinetic ass ...... ts with uncomplicated malaria.
@ast
Population pharmacokinetic ass ...... ts with uncomplicated malaria.
@en
type
label
Population pharmacokinetic ass ...... ts with uncomplicated malaria.
@ast
Population pharmacokinetic ass ...... ts with uncomplicated malaria.
@en
prefLabel
Population pharmacokinetic ass ...... ts with uncomplicated malaria.
@ast
Population pharmacokinetic ass ...... ts with uncomplicated malaria.
@en
P2093
P2860
P50
P356
P1476
Population pharmacokinetic ass ...... ts with uncomplicated malaria.
@en
P2093
Anna Annerberg
Lily Kiricharoen
Niklas Lindegardh
P2860
P304
P356
10.1128/AAC.02318-13
P407
P50
P577
2014-01-21T00:00:00Z